<img src="https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2?size=2" nborder="0" align="left" hspace="5" vspace="5" title="sns insider pvt ltd.png" alt="SNS Insider pvt ltd"/>U.S. Pacemakers Market to Reach $3.88 Billion and Europe $2.48 Billion by 2035, Driven by Advanced Pacing, Remote Monitoring and Growing Cardiac Care Demand.Austin, United States, Aug. 27, 2026 <a href="https://www.globenewswire.com" target="_blank">(GLOBE NEWSWIRE)</a> -- According to SNS Insider, The <a href="https://www.globenewswire.com/Tracker?data=qoRF-1iV7sIGu6k04-lj7VhrGnCvN1usW5Zfx1IQT6fMV_X0I8G16a3zNAFDw2_Ue1DGgh6QrNe1SJAc7PxzO_vVojqvEF8qeM0z8rE1-GhnN392lqGDB883k3S7SQd2eCaUfaw9W3dZ_qTaV4IsPA==" rel="nofollow" target="_blank" title="Pacemakers Market size">Pacemakers Market size</a> was valued at USD 5.97 Billion in 2025 and is projected to reach USD 10.35 Billion by 2035, expanding at a CAGR of 5.66% from 2026 to 2035. Growth is driven by increasing prevalence of cardiovascular diseases and cardiac conduction disorders, aging population, increased use of leadless pacemakers, and adoption of cardiac monitoring solutions with connectivity capabilities. Pacemakers will continue to be vital for bradycardia, heart blocks, sick sinus syndrome, and other arrhythmia conditions. Innovation activities are centered around leadless pacemakers, MR-compatible pacemakers, cardiac conduction system pacing, and AI-powered monitoring platforms. <img alt="Pacemakers Market" height="400" src="https://ml.globenewswire.com/Resource/Download/86e7c2c2-06aa-494e-b7b2-082d1791ab58/pacemakers-market.jpg" width="600" data-dpi="96" data-filename="Pacemakers-Market.jpg" /> Download the Pacemakers Market Sample Report: <a href="https://www.globenewswire.com/Tracker?data=oUyyGVtUweRhRxYLFYR8822iReWjQdzjHVr_HxaCaVHSBs2PhkpR9hA4o3KBQhhHDVIdai2m9OowX1gjiS4t_fBhWCjDcNqdtoY2zL8JN6oJYQdgwQjnDunPf0nBNnMaDPYsNu9uAuRbYb5deHO9noFvreuU4DZkLgW3B9HIKcM=" rel="nofollow" target="_blank" title="">https://www.snsinsider.com/sample-request/5916</a> Pacemakers Market Report: Key Highlights <ul type="disc"><li style="margin-top:0cm; margin-bottom:8pt;">Market size, 2025: USD 5.97 Billion</li><li style="margin-top:0cm; margin-bottom:8pt;">Market forecast, 2035: USD 10.35 Billion</li><li style="margin-top:0cm; margin-bottom:8pt;">CAGR: 5.66% from 2026 to 2035</li><li style="margin-top:0cm; margin-bottom:8pt;">Largest product segment: Implantable pacemakers, 65.0% share in 2025</li><li style="margin-top:0cm; margin-bottom:8pt;">Largest technology segment: Dual-chamber pacemakers, approximately 48% share in 2025</li><li style="margin-top:0cm; margin-bottom:8pt;">Largest application: Bradycardia, 24.5% share in 2025</li><li style="margin-top:0cm; margin-bottom:8pt;">Largest end user: Hospitals &amp; cardiac centers, approximately 65% share in 2025</li><li style="margin-top:0cm; margin-bottom:8pt;">Fastest-growing product segment: External/transcutaneous pacemakers</li><li style="margin-top:0cm; margin-bottom:8pt;">Fastest-growing technology: Leadless pacemakers</li><li style="margin-top:0cm; margin-bottom:8pt;">Fastest-growing application: Congestive heart failure/CRT</li><li style="margin-top:0cm; margin-bottom:8pt;">Fastest-growing end user: Ambulatory surgical centers</li><li style="margin-top:0cm; margin-bottom:8pt;">Fastest-growing region: Asia Pacific</li></ul> Market Relevance The demand for pacemakers is growing due to the growth in conduction disorders, which is associated with the aging population. At the same time, technology is being developed to minimize problems associated with leads, increase accuracy of pacing, and monitor patients continuously. Leadless pacemakers are gaining popularity due to their ability to bypass traditional transvenous leads and device pockets. Additionally, remote monitoring technologies help doctors assess the performance of the device and condition of the patient. Market Overview In the market for Pacemakers, there is a move away from traditional pacemakers to more sophisticated cardiac rhythm management devices. These include leadless pacemakers, MRI compatible pacemakers, AI driven device optimization, conduction system pacing, and digital monitoring. In 2024, Abbott gained wider approval from the FDA for the use of its AVEIR DR dual-chamber leadless pacemaker system. This allows for atrial and ventricular pacemaking without transvenous leads. Strategic Market Outlook Leadless pacing, conduction system pacing, and remote monitoring present huge growth opportunities in the market for Pacemakers. The development of dual chamber leadless pacers is helping increase the target base, whereas digital monitoring helps manage the devices in the long run. Device costs and reimbursement issues continue to be the key barriers, especially in developing countries with public health care programs that cannot afford high-end cardiac devices. Regional Analysis North America continued to be the leading regional Pacemakers Market in 2025. In North America, the U.S. accounted for roughly 87.4% revenue, and Canada accounted for roughly 12.6%. The U.S. Pacemakers Market was valued at approximately USD 2.24 Billion in 2025 and is expected to reach approximately USD 3.88 Billion by 2035, growing at a CAGR of approximately 5.65%. Factors, such as well-established electrophysiology infrastructure, established reimbursement policy, and rapid adoption of new pacing technologies help drive the market. The Europe Pacemakers Market was valued at USD 1.55 Billion in 2025 and is forecast to reach USD 2.48 Billion by 2035, growing at a CAGR of 4.81% from 2026 to 2035. In 2025, Germany accounted for approximately 22.3% of revenue in the European Pacemakers Market, due to well-developed cardiac care infrastructure and device reimbursement. Asia Pacific region holds the position of the fastest-growing regional market. In 2025, China accounted for roughly 44.8% of Asia Pacific revenue, owing to developments in the cardiac care infrastructure and healthcare investments, and uptake of advanced pacing systems. Japan, South Korea, and India are making contributions to the regional expansion of the market. Middle East &amp; Africa: In 2025, Saudi Arabia accounted for roughly 31.2% of regional revenue. Latin America: In 2025, Brazil accounted for roughly 44.2% of regional revenue. Buy the Pacemakers Market Report with Competitive Analysis and 2035 Forecast: <a href="https://www.globenewswire.com/Tracker?data=oUyyGVtUweRhRxYLFYR8822iReWjQdzjHVr_HxaCaVFhhrENsSFCbTr6aCAdl_vV0R9J-fU6xsWIPgqSJInGtzrY0wgibwIaGDcCfLyXL0t-lJjAxldduDHUPEA3rIu10DZevYsj1sOZlEgHqLk5yQ==" rel="nofollow" target="_blank" title="">https://www.snsinsider.com/checkout/5916</a> Pacemakers Market Segment Analysis By Product: Implantable pacemakers dominated the market, contributing to 65.0% of the market share in 2025, owing to their already proven applications in rhythm regulation. The external and transcutaneous pacemakers are the most rapidly growing product types, owing to their demand in emergencies and surgery. By Technology: Dual-Chamber Pacemakers accounted for about 48% share in 2025 due to their capacity to achieve AV synchrony. Leadless pacemakers have been the most promising technology owing to their ability to increase patient suitability while decreasing complications from traditional leads. By Application: Bradycardia held a share of 24.5% of the market in 2025, being the largest application. The second fastest growing application would be Congestive heart failure/CRT, driven by rising adoption of Cardiac Resynchronization Therapy among heart failure patients. By End User: Hospital/Cardiac centers have around 65% market share owing to their availability of catheterization labs, electrophysiology facilities, and trained cardiac specialists. Ambulatory surgery centers are growing fastest as a category due to the slow transfer of some low-risk procedures from hospitals to outpatient centers. Key Pacemakers Market Trends <ul type="disc"><li style="margin-top:0cm; margin-bottom:8pt;">Increasing adoption of leadless pacemakers</li><li style="margin-top:0cm; margin-bottom:8pt;">Expansion of MRI-compatible pacing systems</li><li style="margin-top:0cm; margin-bottom:8pt;">Growing use of remote cardiac monitoring</li><li style="margin-top:0cm; margin-bottom:8pt;">Rising adoption of conduction system pacing</li><li style="margin-top:0cm; margin-bottom:8pt;">Increasing integration of AI-enabled device management</li><li style="margin-top:0cm; margin-bottom:8pt;">Development of dual-chamber leadless pacemakers</li><li style="margin-top:0cm; margin-bottom:8pt;">Growing use of outpatient cardiac procedures</li></ul> Competitive Landscape The Pacemakers Market includes established cardiac rhythm management companies and emerging device manufacturers competing across implantable pacemakers, leadless systems, CRT technologies, monitoring platforms, and advanced pacing solutions. Major Companies in the Pacemakers Market <ul type="disc"><li style="margin-top:0cm; margin-bottom:8pt;">Medtronic PLC</li><li style="margin-top:0cm; margin-bottom:8pt;">Abbott Laboratories (St. Jude Medical)</li><li style="margin-top:0cm; margin-bottom:8pt;">Boston Scientific Corporation</li><li style="margin-top:0cm; margin-bottom:8pt;">BIOTRONIK SE &amp; Co. KG</li><li style="margin-top:0cm; margin-bottom:8pt;">MicroPort Scientific Corporation</li><li style="margin-top:0cm; margin-bottom:8pt;">Lepu Medical Technology Co., Ltd.</li><li style="margin-top:0cm; margin-bottom:8pt;">Shree Pacetronix Ltd.</li><li style="margin-top:0cm; margin-bottom:8pt;">Oscor Inc.</li><li style="margin-top:0cm; margin-bottom:8pt;">Osypka Medical GmbH</li><li style="margin-top:0cm; margin-bottom:8pt;">Shenzhen Qinming Medical Instruments Co., Ltd.</li><li style="margin-top:0cm; margin-bottom:8pt;">Shenzhen Pacemaker Medical Co., Ltd.</li><li style="margin-top:0cm; margin-bottom:8pt;">Sorin Group (LivaNova PLC)</li><li style="margin-top:0cm; margin-bottom:8pt;">Cook Medical Inc.</li><li style="margin-top:0cm; margin-bottom:8pt;">Braile Biopharma</li><li style="margin-top:0cm; margin-bottom:8pt;">CCC Medical Devices</li><li style="margin-top:0cm; margin-bottom:8pt;">Ela Medical (MicroPort)</li><li style="margin-top:0cm; margin-bottom:8pt;">Cardioelectronica</li><li style="margin-top:0cm; margin-bottom:8pt;">Vitatron</li><li style="margin-top:0cm; margin-bottom:8pt;">Sanan Medical</li><li style="margin-top:0cm; margin-bottom:8pt;">Medico S.p.A.</li></ul> Explore the Complete Pacemakers Market Report: <a href="https://www.globenewswire.com/Tracker?data=oUyyGVtUweRhRxYLFYR8822iReWjQdzjHVr_HxaCaVGNiVmqCiKJMiO2YBb_b2XbTpSSdDqCHikgB1foNjuzfO0gx2ypsTKeoEwB_8mKYhRUMLjFmGU-gS4Yp5Nyv9cAgl2vRtWNDRtD5G0W32XNkoOUG7ktE0FOsB7JJ7xy7Uya7o8PkvbAG_nSWz2yVXeX" rel="nofollow" target="_blank" title="">https://www.snsinsider.com/reports/pacemakers-market-5916</a> <pre>CONTACT: About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315-961-9094 (US)
Email: info@snsinsider.com</pre> <img alt="" src='https://ml.globenewswire.com/media/M2U4M2E2ZjctYWU5Mi00ZWRmLThhM2UtN2M5YTIwZTA2ZDNmLTEyNjg4MTktMjAyNi0wOC0yNy1lbg==/tiny/SNS-Insider-pvt-ltd.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Pacemakers Market Size to Reach $10.35 Billion by 2035 as Leadless Pacing Reshapes Cardiac Care – SNS Insider

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn